Senate Finance Committee Chairman Ron Wyden (D-OR) has announced the release of new findings in his ongoing investigation into the tax practices of multinational pharmaceutical companies. --- Wyden Releases New Findings in Ongoing Pharma Tax Investigation Democratic Staff Investigation Found 2017 Republican Tax Law Cut Big Pharma's Tax Rate by 40 Percent; U.S. is Big Pharma's Biggest Market, But Drug Companies Report 75 Percent of Profit Overseas Washington, D.C. – Senate Finance Committee Chairman Ron Wyden (D-Ore.) today released a new Democratic staff memorandum with updated findings from his ongoing investigation into Big Pharma's tax practices. The memorandum reveals for...